1-8 of 8
Ramzi Dagher
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Randomized Trial and Pharmacokinetic Study of Pegfilgrastim versus Filgrastim after Dose-Intensive Chemotherapy in Young Adults and Children with Sarcomas

Free
Elizabeth Fox, Brigitte C. Widemann, Douglas S. Hawkins, Nalini Jayaprakash, Ramzi Dagher, Alberta A. Aikin, Donna Bernstein, Lauren Long, Crystal Mackall, Lee Helman, Seth M. Steinberg, Frank M. Balis
Journal: Clinical Cancer Research
Clin Cancer Res (2009) 15 (23): 7361–7367.
https://doi.org/10.1158/1078-0432.CCR-09-0761
Published: 30 November 2009
View articletitled, Randomized Trial and Pharmacokinetic Study of Pegfilgrastim versus Filgrastim after Dose-Intensive Chemotherapy in Young Adults and Children with Sarcomas
Open the PDF for Randomized Trial and Pharmacokinetic Study of Pegfilgrastim versus Filgrastim after Dose-Intensive Chemotherapy in Young Adults and Children with Sarcomas in another window
Journal Articles

Tasigna for Chronic and Accelerated Phase Philadelphia Chromosome–Positive Chronic Myelogenous Leukemia Resistant to or Intolerant of Imatinib

Free
Maitreyee Hazarika, Xiaoping Jiang, Qi Liu, Shwu-Luan Lee, Roshni Ramchandani, Christine Garnett, Micheal S. Orr, Rajeshwari Sridhara, Brian Booth, John K. Leighton, William Timmer, Ravi Harapanhalli, Ramzi Dagher, Robert Justice, Richard Pazdur
Journal: Clinical Cancer Research
Clin Cancer Res (2008) 14 (17): 5325–5331.
https://doi.org/10.1158/1078-0432.CCR-08-0308
Published: 02 September 2008
View articletitled, Tasigna for Chronic and Accelerated Phase Philadelphia Chromosome–Positive Chronic Myelogenous Leukemia Resistant to or Intolerant of Imatinib
Open the PDF for Tasigna for Chronic and Accelerated Phase Philadelphia Chromosome–Positive Chronic Myelogenous Leukemia Resistant to or Intolerant of Imatinib in another window
Journal Articles

Ixabepilone in Combination with Capecitabine and as Monotherapy for Treatment of Advanced Breast Cancer Refractory to Previous Chemotherapies

Free
Robert J. Lechleider, Edvardas Kaminskas, Xiaoping Jiang, Robeena Aziz, Julie Bullock, Ravindra Kasliwal, Ravi Harapanhalli, Sarah Pope, Rajeshwari Sridhara, John Leighton, Brian Booth, Ramzi Dagher, Robert Justice, Richard Pazdur
Journal: Clinical Cancer Research
Clin Cancer Res (2008) 14 (14): 4378–4384.
https://doi.org/10.1158/1078-0432.CCR-08-0015
Published: 15 July 2008
View articletitled, Ixabepilone in Combination with Capecitabine and as Monotherapy for Treatment of Advanced Breast Cancer Refractory to Previous Chemotherapies
Open the PDF for Ixabepilone in Combination with Capecitabine and as Monotherapy for Treatment of Advanced Breast Cancer Refractory to Previous Chemotherapies in another window
Journal Articles

Bortezomib for the Treatment of Mantle Cell Lymphoma

Free
Robert C. Kane, Ramzi Dagher, Ann Farrell, Chia-Wen Ko, Rajeshwari Sridhara, Robert Justice, Richard Pazdur
Journal: Clinical Cancer Research
Clin Cancer Res (2007) 13 (18): 5291–5294.
https://doi.org/10.1158/1078-0432.CCR-07-0871
Published: 17 September 2007
View articletitled, Bortezomib for the Treatment of Mantle Cell Lymphoma
Open the PDF for Bortezomib for the Treatment of Mantle Cell Lymphoma in another window
Journal Articles

Vorinostat for Treatment of Cutaneous Manifestations of Advanced Primary Cutaneous T-Cell Lymphoma

Free
Bhupinder S. Mann, John R. Johnson, Kun He, Rajeshwari Sridhara, Sophia Abraham, Brian P. Booth, Leigh Verbois, David E. Morse, Josephine M. Jee, Sarah Pope, Ravi S. Harapanhalli, Ramzi Dagher, Ann Farrell, Robert Justice, Richard Pazdur
Journal: Clinical Cancer Research
Clin Cancer Res (2007) 13 (8): 2318–2322.
https://doi.org/10.1158/1078-0432.CCR-06-2672
Published: 16 April 2007
View articletitled, Vorinostat for Treatment of Cutaneous Manifestations of Advanced Primary Cutaneous T-Cell Lymphoma
Open the PDF for Vorinostat for Treatment of Cutaneous Manifestations of Advanced Primary Cutaneous T-Cell Lymphoma in another window
Journal Articles

Approval Summary: Sunitinib for the Treatment of Imatinib Refractory or Intolerant Gastrointestinal Stromal Tumors and Advanced Renal Cell Carcinoma

Free
Vicki L. Goodman, Edwin P. Rock, Ramzi Dagher, Roshni P. Ramchandani, Sophia Abraham, Jogarao V.S. Gobburu, Brian P. Booth, S. Leigh Verbois, David E. Morse, Cheng Yi Liang, Nallaperumal Chidambaram, Janet X. Jiang, Shenghui Tang, Kooros Mahjoob, Robert Justice, Richard Pazdur
Journal: Clinical Cancer Research
Clin Cancer Res (2007) 13 (5): 1367–1373.
https://doi.org/10.1158/1078-0432.CCR-06-2328
Published: 01 March 2007
View articletitled, Approval Summary: Sunitinib for the Treatment of Imatinib Refractory or Intolerant Gastrointestinal Stromal Tumors and Advanced Renal Cell Carcinoma
Open the PDF for Approval Summary: Sunitinib for the Treatment of Imatinib Refractory or Intolerant Gastrointestinal Stromal Tumors and Advanced Renal Cell Carcinoma in another window
Journal Articles

Approval Summary: Docetaxel in Combination with Prednisone for the Treatment of Androgen-Independent Hormone-Refractory Prostate Cancer

Free
Ramzi Dagher, Ning Li, Sophia Abraham, Atiqur Rahman, Raji Sridhara, Richard Pazdur
Journal: Clinical Cancer Research
Clin Cancer Res (2004) 10 (24): 8147–8151.
https://doi.org/10.1158/1078-0432.CCR-04-1402
Published: 28 December 2004
View articletitled, Approval Summary: Docetaxel in Combination with Prednisone for the Treatment of Androgen-Independent Hormone-Refractory Prostate Cancer
Open the PDF for Approval Summary: Docetaxel in Combination with Prednisone for the Treatment of Androgen-Independent Hormone-Refractory Prostate Cancer in another window
Journal Articles

Approval Summary: Imatinib Mesylate in the Treatment of Metastatic and/or Unresectable Malignant Gastrointestinal Stromal Tumors

Free
Ramzi Dagher, Martin Cohen, Gene Williams, Mark Rothmann, Jogarao Gobburu, Gabriel Robbie, Atiqur Rahman, Gang Chen, Ann Staten, Donna Griebel, Richard Pazdur
Journal: Clinical Cancer Research
Clin Cancer Res (2002) 8 (10): 3034–3038.
Published: 01 October 2002
View articletitled, Approval Summary: Imatinib Mesylate in the Treatment of Metastatic and/or Unresectable Malignant Gastrointestinal Stromal Tumors
Open the PDF for Approval Summary: Imatinib Mesylate in the Treatment of Metastatic and/or Unresectable Malignant Gastrointestinal Stromal Tumors in another window